JK Pharmachem Board of Directors
Get the latest insights into the leadership at JK Pharmachem. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Deep Chandra Jain | Director |
| Kailash Bhansali | Director |
| Prakash Chandra Jain | Director |
| Pramod Kapoor | Director |
| Sudhir A Bidkar | Director |
| Dr S K Sagar | Director |
| T S Surendranath | Director |
| Shweta Girotra | Deputy Company Secretary |
JK Pharmachem FAQs
The board at JK Pharmachem consists of experienced professionals, including Deep Chandra Jain, Kailash Bhansali, and others, overseeing the company’s strategic and corporate governance.
Directors at JK Pharmachem are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Deep Chandra Jain is the current chairman at JK Pharmachem.
Executive directors at JK Pharmachem are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, JK Pharmachem adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At JK Pharmachem, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
